These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 193725)

  • 1. [Comparative effect of chlorpromazine, imipramine and papaverine on the blood platelet function].
    Bartel' V; Gluza E; Markvardt F
    Farmakol Toksikol; 1976; 39(3):296-301. PubMed ID: 193725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of trapidil and papaverine on thrombocyte aggregation and phosphodiesterase activity].
    Glusa E
    Farmakol Toksikol; 1986; 49(6):48-9. PubMed ID: 3028860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of drugs on the activity of thrombocytes 3,5-cyclic AMP phosphodiesterase.
    Rysánek K; Spánkova H; Mlejnkova M; Synek P
    Int J Clin Pharmacol; 1974 Jul; 10(1):30-2. PubMed ID: 4368616
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
    Asano T; Ochiai Y; Hidaka H
    Mol Pharmacol; 1977 May; 13(3):400-6. PubMed ID: 195193
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of serotonin-induced platelet aggregation in relation to thrombus production.
    Michal F; Penglis F
    J Pharmacol Exp Ther; 1969 Apr; 166(2):276-84. PubMed ID: 5776985
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of tricyclic antidepressants on phosphodiesterase. Correlation between aggregability and thrombocyte metabolism.
    Rysànek K; König J; Spànkovà H; Mlejnkovà M
    Act Nerv Super (Praha); 1973 May; 15(2):126-7. PubMed ID: 4356597
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of verapamil on serotonergic mechanisms in the rat blood platelets.
    Pietraszek M; Chabielska E; Malinowska B; Buczko W
    Pol J Pharmacol Pharm; 1988; 40(1):81-6. PubMed ID: 3237561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC; Guccione MA; Packham MA; Mustard JF
    Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of functional compartments of cyclic AMP in rat platelets by the use of phosphodiesterase inhibitors.
    Ashida S; Sakuma K
    Adv Second Messenger Phosphoprotein Res; 1992; 25():229-39. PubMed ID: 1313259
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of the platelet 5-HT2A receptor function by long-term imipramine treatment in endogenous depression.
    Gómez-Gil E; Gastó C; Carretero M; Díaz-Ricart M; Salamero M; Navinés R; Escolar G
    Hum Psychopharmacol; 2004 Jun; 19(4):251-8. PubMed ID: 15181653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1-aminoadamantanes on adenine nucleotide and serotonin storage in blood platelets.
    Wesemann W; Muschalek G; Stöltzing H; von Pusch I; Paul N
    Eur J Cell Biol; 1981 Dec; 26(1):158-67. PubMed ID: 7327177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
    Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
    J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of prothixen and related compounds on serotonin absorption by human thrombocytes].
    Oksenkrug GF
    Biull Eksp Biol Med; 1975 Aug; 80(8):74-7. PubMed ID: 1182309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood platelet function, medicinal agents, and other chemical entities.
    Lasslo A
    Fed Proc; 1984 Apr; 43(5):1382-9. PubMed ID: 6323230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of various drugs on platelet aggregation and liberation of platelet factor 4 (anti-heparin factor)].
    Farbiszewski R; Niewiarowski S; Poplawski A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):470-6. PubMed ID: 4193163
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological studies on drugs inhibiting platelets aggregation].
    Tanaka K
    Rinsho Ketsueki; 1984 Jul; 25(7):992-7. PubMed ID: 6094884
    [No Abstract]   [Full Text] [Related]  

  • 18. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current concepts on the sorption, deposition and release of serotonin by blood platelets].
    Dorofeev VM; Nestaĭko GV
    Usp Sovrem Biol; 1973; 75(3):379-87. PubMed ID: 4603440
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of cis-platinum on some platelet functions in vitro.
    Kubisz P; Seghier F; Klener P; Holan J
    Neoplasma; 1983; 30(4):391-4. PubMed ID: 6684214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.